Michel Rider

Global Head of Digital R&D • Digital

Sanofi

About Me

Michel is Sanofi’s Global Head of Digital R&D and is accountable for all applications, data, and AI/ML assets applied to discovery, development, and market support of medicines and vaccines. Prior to this she held leadership roles at GSK and Merck in both business and digital/tech, was management consultant with Accenture, and led a commercial software company focused on digitalizing clinical patient dataflow. She holds a BS in Microbiology and an MS in Management of Information Systems.

Hear My Insights

Scientific AI: The Next Frontier for R&D and Engineering

Scientific AI is revolutionizing R&D by accelerating discovery and creating new hypotheses to investigate. Trained on scientific data and powered by AI agents, these models enhance every stage of research—from simulations and lab work to real-world applications—across fields from drug discovery to aerospace engineering. By combining open and proprietary data with expertise, Scientific AI breaks down traditional research silos and unlocks cross-disciplinary insights. To harness the full potential of this competitive advantage, organizations will need to align business and science goals, invest in digital infrastructure, and build agile, multidisciplinary teams.

Augmented clinical trial with AI

Sanofi is transforming clinical trials with AI—making them faster, more inclusive, and safer. From smarter patient recruitment to real-time safety monitoring, innovation is accelerating access to better treatments for all.